norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study

著录项

• 来源
  《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共2页
• 作者

  Traussnigg Stefan; Schattenberg Jorn M.; Demir Muenevver; Wiegand Johannes; Geier Andreas; Teuber Gerlinde; Hofmann Wolf Peter; Kremer Andreas E.; Spreda Frank; Kluwe Johannes; Petersen Joerg; Boettler Tobias; Halilbasic Emina; Greinwald Roland; Proels Markus; Manns Michael P.; Fickert Peter; Trauner Michael H.;

  展开▼
• 作者单位

  Med Univ Vienna Div Gastroenterol &

  Hepatol Dept Internal Med 3 Vienna Austria;

  Johannes Gutenberg Univ Mainz Div Hepatol Dept Internal Med 1 Mainz Germany;

  Univ Cologne Div Gastroenterol &

  Hepatol Dept Internal Med Cologne Germany;

  Univ Leipzig Div Gastroenterol &

  Hepatol Dept Internal Med Leipzig Germany;

  Univ Wurzburg Dept Med Clin Wurzburg Germany;

  Teubner Consulting &

  Res UG Frankfurt Germany;

  Friedrich Alexander Univ Dept Med 1 Erlangen Germany;

  Univ Hosp Hamburg Eppendorf Div Hepatol Dept Internal Med Hamburg Germany;

  Asklepios Clin St Georg Ifi Studies &

  Projects Hamburg Germany;

  Univ Freiburg Div Gastroenterol &

  Hepatol Dept Internal Med 2 Freiburg Germany;

  Med Univ Vienna Div Gastroenterol &

  Hepatol Dept Internal Med 3 Vienna Austria;

  Dr Falk Pharma GmbH Freiburg Germany;

  Dr Falk Pharma GmbH Freiburg Germany;

  Hannover Med Sch Dept Gastroenterol Hepatol &

  Endocrinol Hannover Germany;

  Med Univ Graz Div Gastroenterol &

  Hepatol Dept Internal Med 1 Graz Austria;

  Med Univ Vienna Div Gastroenterol &

  Hepatol Dept Internal Med 3 Vienna Austria;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 消化系及腹部疾病;
• 关键词